We just released the seventh edition of the Jefferies Healthcare Temperature Check, our annual research report that explores the issues at the top of the healthcare agenda. Capturing a record number of views from senior leaders and investors from across the global Healthcare sector, the report and its findings act as an essential source of insight to complement the information-sharing and connections we can expect at our London Healthcare Conference this week. It has been another challenging year for global markets, characterized by a higher-for-longer interest rate environment, continued geopolitical instability and democratic uncertainty with almost half of the worldâs population voting in national elections â more than ever in history. However, Healthcare has again demonstrated its ability to adapt, innovate and prove its resilience. See full results here: http://spklr.io/6042xkcs #JefferiesHealthcare
Jefferies
Investment Banking
New York City, New York 427,703 followers
Jefferies, the global investment banking firm serving clients for more than 60 years.
About us
Jefferies is a leading global, full-service investment banking and capital markets firm that provides advisory, sales and trading, research and wealth and asset management services. With more than 40 offices around the world, we offer insights and expertise to investors, companies and governments. More about our company can be found at www.jefferies.com.
- Website
-
http://Jefferies.com
External link for Jefferies
- Industry
- Investment Banking
- Company size
- 5,001-10,000 employees
- Headquarters
- New York City, New York
- Type
- Public Company
- Founded
- 1962
- Specialties
- Investment Banking, Fixed Income, Equities, Research & Strategy, Wealth Management, and Financial Services
Locations
Employees at Jefferies
Updates
-
Weâre delighted to welcome John Maraganore to Jefferies, who joins as Senior Advisor. He is a proven veteran in the biopharma space developed through an illustrious career as CEO of Alnylam Pharmaceuticals and then as a trusted investor, advisor and board member to an array of companies. He also led the advancement of RNAi therapeutics as a whole new class of medicines, bringing four approved medicines to patients around the world. Johnâs decades of experience at the center of the biopharma industry will be an exceptional asset to Jefferiesâ healthcare franchise as it deepens its position as a trusted advisor and thought partner at the nexus of public, private companies, and capital. http://spklr.io/6042xX9g
-
Jefferies is pleased to have served as financial advisor to Anaqua, a portfolio company of Astorg and a global intellectual property (âIPâ) management software platform, in its proposed sale to Nordic Capital. Anaquaâs platform provides integrated software, data, analytics and related services across the entire IP value chain. This partnership will propel Anaqua into the next phase of growth, as the company works to expand its global capabilities and depth of offerings for new and existing customers. The transaction adds to Jefferiesâ track record of advising on marquee transactions in the software and legal technology space.
-
Jefferies recently hosted an Alumni event presented by our Financial Sponsors Group (FSG), bringing together over 100 current and former employees from across the firm, including FSG leaders Jeffrey Greenip, Global Head of Financial Sponsors, and Mike Simpson, Managing Director, who took the opportunity to welcome past colleagues. It was a pleasure to see so many returning Alumni, who have contributed to Jefferiesâ ongoing success. We are incredibly grateful for our Alumni Network and the ongoing relationship-building it fosters. Jefferies looks forward to hosting many more events as our network continues to grow. Watch below for a glimpse into the event and to hear from Alumni about their Jefferies experience.
-
Ahead of Jefferiesâ annual Global Healthcare Conference kicking off this week we sat down with Tommy Erdei, Joint Global Head of Healthcare Investment Banking, for his outlook on the healthcare sector and key trends shaping 2025. From his perspective, Healthcareâs momentum will continue to build. Private equity activity has remained steady, relative to other sectors. There are robust pipelines of innovation. And industry leaders are sitting on large cash reserves, supporting strategic M&A. Read more about the sector and Erdeiâs perspective here: http://spklr.io/6047xzqH #JefferiesHealthcare
-
We were honored to be joined by John Amaechi OBE, for a thought-provoking fireside chat that was facilitated by Rishi Bhuchar, Global Co-Head of Real Estate and EMEA Head of REGAL. As a respected organizational psychologist, John provided insights on how we all can transform the workplace by building an inclusive culture, practicing empathy and demonstrating accountability. Thank you to JEMS and JMOSAIC+, Jefferiesâ Ethnic Minority and LGBTQ+ Employee Resource Groups, for hosting this engaging discussion. We look forward to embracing Johnâs powerful perspective and turning these learnings into actions to foster an environment where every individual can thrive! #JefferiesDEI #JEMS #JMOSAIC+
-
+1
-
This year marks the 15th anniversary of the largest Healthcare-dedicated conference in Europe â Jefferies London Healthcare Conference taking place November 19-21. The conference will once again feature leading global public and private companies from the pharmaceuticals, biotechnology, medical technology, and Healthcare services sectors. In advance of the conference, we sat down with Tommy Erdei, Jefferies Global Joint Head of Healthcare Investment Banking, for a Q&A on a range of topics from private equity activity in the Healthcare sector to emerging dynamics at Healthcare companies. Hear from him below. #JefferiesHealthcare
-
Please welcome Oliver Wight as Head of Distressed Sales in New York and Aurelia Cai as Co-Head of EMEA Loans & Distressed in London. Both will further strengthen our leading distressed trading capabilities. They are both fluent across the product spectrum, including high yield, leveraged loans, investment grade, emerging markets, municipals, derivatives, structured products, and financing and will add to our leading distressed trading franchise. Welcome to #TeamJEF
-
Steven DeSanctis, Jefferies' Equity Strategist covering small and mid-cap companies, spoke to The Economist for their weekly Schumpeter column following the US election. He noted that the Russell 2000, the index tracking the smallest public companies in the US, has seen impressive growth in the past week, a "welcome change" for companies whose returns have "lagged behind those of corporate superstars for about ten years". Read more: http://spklr.io/6046xG7g
-
Please congratulate Emily Corzel, Senior Vice President on Jefferiesâ Capital Introduction team, on her ranking as one of the 50 leading women in hedge funds. The Hedge Fund Journal recognizes her as a strategic advisor to some of the most important clients on the Jefferies Prime Services platform. Since joining Jefferies in 2018, Emily has built out and managed the West Coast Capital Introductions program, where she helps alternative fund managers execute their marketing strategy and works with the institutional allocator community as they build out their alternative investment programs. Congratulations, Emily!
Similar pages
Browse jobs
Stock
JEF
NYSE
20 minutes delay
$74.62
0.79 (1.07%)
- Open
- 72.79
- Low
- 72.55
- High
- 74.74
Data from Refinitiv
See more info on